Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.

Biotechnology

Indapta Therapeutics

Indapta Therapeutics' headquarters in San Francisco, CA, United States

Mark W. Frohlich

Robert Sikorski

Stefanie Mandl-Cashman

Austin Bigley

Neil Sankar

Vaughn Smider

Sungjin Kim

Ronald Martell

Nina Shah

Todd A. Fehniger

John Sunwoo

Fabio Pucci

Lori Hu

Laura Stoppel

Jim Weiss

Ran Nussbaum

Description

People (4)

Ronald Martell

Neil Sankar

Jim Weiss

Stefanie Mandl-Cashman

Jobs